EFTA00317114.pdf

Report Status: Final li bj Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR780669K Client #:78300020 56W5265 EPSTEIN, JEFFREY Requisition: 0006001 MOSKOWITZ,BRUCE W DOB: 01/20/1953 AGE: 65 BRUCE MOSKOWITZ,MD Gender: M Attn: NATIONWIDE ACCOUNT Collected: 08/03/2018 Phone: 1411 N FLAGLER DR STE 7100 Received: 08/07/2018 I 08:58 EDT Patient ID: 19530120MJE WEST PALM BEACH,FL 33401-3418 Reported: 08/07/2018 I 08:59 EDT Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab LIPID PANEL, STANDARD CHOLESTEROL, TOTAL 244 H <200 mg/dL MI HDL CHOLESTEROL 29 L >40 mg/dL MI TRIGLYCERIDES 855 H <150 mg/dL MI LDL-CHOLESTEROL mg/dL (talc) MI LDL cholesterol not calculated. Triglyceride levels greater than 400 mg/dL invalidate calculated LDL results. Reference range: <100 Desirable range <100 mg/dL for primary prevention; <70 mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al. JAMA. 2013;310(19): 2061-2068 (http://education.QuestDiagnostics.com/faq/FAQ164) CHOL/HDLC RATIO 8.4 H <5.0 (talc) MI NON HDL CHOLESTEROL 215 H <130 mg/dL (talc) MI For patients with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.2 mg/L TP The above test was performed; however, the specimen was lipemic. Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 Years: hs-CRP mg/L Risk According to AHA/CDC Guidelines <1.0 Lower relative cardiovascular risk. 1.0-3.0 Average relative cardiovascular risk. 3.1-10.0 Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation. >10.0 Persistent elevation, upon retesting, may be associated with infection and inflammation. HONOCYSTEINE 16.1 H <11.4 umol/L MI Homocysteine is increased by functional deficiency of folate or vitamin B12. Testing for methylmalonic acid CLIENT SERVICES:866.697.8378 SPECIMEN: MR780669K PAGEI0F5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00317114  Report Status: Final raj Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR780669K Client #: 78300020 EPSTEIN, JEFFREY Collected: 08/03/2018 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 65 Received: 08/07/2018 I 08:58 EDT Gender: M Reported: 08/07/2018 I 08:59 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab differentiates between these deficiencies. Other causes of increased homocysteine include renal failure, folate antagonists such as methotrexate and phenytoin, and exposure to nitrous oxide. COMPREHENSIVE METABOLIC MI PANEL GLUCOSE 106 H 65-99 mg/dL Fasting reference interval For someone without known diabetes, a glucose value between 100 and 125 mg/dL is consistent with prediabetes and should be confirmed with a follow-up test. UREA NITROGEN (BUN) 22 7-25 mg/dL CREATININE 1.11 0.70-1.25 mg/dL For patients >49 years of age, the reference limit for Creatinine is approximately 13% higher for people identified as African-American. eGFR NON-AFR. AMERICAN 69 > OR = 60 mL/min/1.73m2 eGFR AFRICAN AMERICAN 80 > OR = 60 mL/min/1.73m2 BUN/CREATININE RATIO NOT APPLICABLE 6-22 (calc) SODIUM 142 135-146 mmol/L POTASSIUM 4.4 3.5-5.3 mmoi/L CHLORIDE 103 98-110 mmol/L CARBON DIOXIDE 21 20-31 mmol/L CALCIUM 10.5 R 8.6-10.3 mg/dL PROTEIN, TOTAL 7.4 6.1-8.1 g/dL ALBUMIN 4.6 3.6-5.1 g/dL GLOBULIN 2.8 1.9-3.7 g/dL (calc) ALBUMIN/GLOBULIN RATIO 1.6 1.0-2.5 (calc) BILIRUBIN, TOTAL 0.7 0.2-1.2 mg/dL ALKALINE PHOSPHATASE 61 40-115 U/L AST 23 10-35 U/L ALT 38 9-46 U/L HEMOGLOBIN Ale 5.7 H <5.7 % of total Hgb MI For someone without known diabetes, a hemoglobin Alc value between 5.7% and 6.4% is consistent with prediabetes and should be confirmed with a follow-up test. For someone with known diabetes, a value <7% indicates that their diabetes is well controlled. Alc targets should be individualized based on duration of diabetes, age, comorbid conditions, and other considerations. This assay result is consistent with an increased risk of diabetes. Currently, no consensus exists regarding use of hemoglobin Alc for diagnosis of diabetes for children. URIC ACID 7.2 4.0-8.0 mg/dL MI CLIENT SERVICES: 866.697.8378 SPECIMEN: MR780669K PAGE 2 OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00317115  Report Status: Final Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Clientheonnation Specimen: MR780669K Client #: 78300020 EPSTEIN, JEFFREY Collected: 08/03/2018 MOSKOWITZ. BRUCE W DOB: 01/20/1953 AGE: 65 Received: 08/07/2018 I 08:58 EDT Gender: M Reported: 08/07/2018 I 08:59 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab Therapeutic target for gout patients: <6.0 mg/dL TSH 3.41 0.40-4.50 mIU/L MI T4 (THYROXINE), TOTAL 8.3 4.5-12.0 mcg/dL MI FREE T4 INDEX (T7) 2.4 1.4-3.8 T3 UPTAKE 29 22-35 % MI SED RATE BY MODIFIED MI WESTERGREN 6 < OR= 20 mm/h CBC (INCLUDES DIFF/PLT) MI WHITE BLOOD CELL COUNT 7.5 3.8-10.8 Thousand/uL RED BLOOD CELL COUNT 5.65 4.20-5.80 Million/uL HEMOGLOBIN 16.4 13.2-17.1 g/dL HEMATOCRIT 47.6 38.5-50.0 % MCV 84.2 80.0-100.0 fL MCH 29.0 27.0-33.0 pg MCHC 34.5 32.0-36.0 g/dL RDW 13.9 11.0-15.0 % PLATELET COUNT 301 140-400 Thousand/uL MPV 9.6 7.5-12.5 fL ABSOLUTE NEUTROPHILS 3420 1500-7800 cells/uL ABSOLUTE LYMPHOCYTES 2880 850-3900 cells/uL ABSOLUTE MONOCYTES 705 200-950 cells/uL ABSOLUTE EOSINOPHILS 435 15-500 cells/uL ABSOLUTE BASOPHILS 60 0-200 cells/uL NEUTROPHILS 45.6 LYMPHOCYTES 38.4 MONOCYTES 9.4 EOSINOPHILS 5.8 BASOPHILS 0.8 URINALYSIS, COMPLETE MI See Endnote 2 VITAMIN B12 423 200-1100 pg/mL MI C-REACTIVE PROTEIN 1.5 <8.0 mg/L MI TESTOSTERONE, TOTAL MI MALES (ADULT), IA TESTOSTERONE, TOTAL, MALES (ADULT), IA 206 L 250-827 ng/dL In hypogonadal males, Testosterone, Total, LC/MS/MS, is the recommended assay due to the diminished accuracy of immunoassay at levels below 250 ng/dL. This test code (15983) must be collected in a red-top tube with no gel. PSA, TOTAL 0.6 < OR = 4.0 ng/mL The total PSA value from this assay system is standardized against the WHO standard. The test result will be approximately 20% lower when compared to the equimolar-standardized total PSA (Beckman Coulter). Comparison of serial PSA results should be interpreted with this fact in mind. This test was performed using the Siemens chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. PSA levels, regardless of value, should not be interpreted as absolute CLIENT SERVICES: 866.697.8378 SPECIMEN: MR780669K PAGE30F5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00317116  Report Status: Final raj —.0 Quest Diagnostics' EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR780669K Client #: 78300020 EPSTEIN, JEFFREY Collected: 08/03/2018 MOSKOWITZ. BRUCE W DOB: 01/20/1953 AGE: 65 Received: 08/07/2018 / 08:58 EDT Gender: M Reported: 08/07/2018 / 08:59 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab evidence of the presence or absence of disease. Endnote I * Test not performed. * No specimen received. CLIENT SERVICES: 866.697.8378 SPECIMEN: MR780669K PAGE 4 OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00317117  Report Status: Final raj Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR780669K Client #: 78300020 EPSTEIN, JEFFREY Collected: 08/03/2018 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 65 Received: 08/07/2018 / 08:58 EDT Gender: M Reported: 08/07/2018 / 08:59 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Endocrinology Test Name Result Reference Range Lab VITAMIN D,25.OH,TOTAL,IA 32 30-100 ng/mL MI Vitamin D Status 25-OH Vitamin D: Deficiency: <20 ng/mL Insufficiency: 20 - 29 ng/mL Optimal: > or = 30 ng/mL For 25-OH Vitamin D testing on patients on D2-supplementation and patients for whom quantitation of D2 and D3 fractions is required, the QuestAssureD(TM) 25-OH VIT D, (D2,D3), LC/MS/MS is recommended: order code 92888 (patients >2yrs). For more information on this test, go to: (This link is being provided for informational/ educational purposes only.) Physician Comments: PERFORMING SITE: MI QUEST DIAGNOSTICS.NIIAMI. 10330 COMMERCE PARKWAY. MIRAMAR. FL 33015-3915 Laboratory DUCCIOI: GLEN L. IIORTIN MD PHD. CLIA 1000277334 TP QUEST D1AGNOSTICSTAMPA. 1225 E FOWLER AVE TAMPA. FL 33617.2026 Laboratory Dire,: tor GLEN L HORTIN.MD.FIID. CLIA 1000291120 CLIENT SERVICES: 866.697.8378 SPECIMEN: MR780669K PAGE 5 OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00317118